BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29945478)

  • 1. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
    Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
    Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
    Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.
    Kweldam CF; Wildhagen MF; Steyerberg EW; Bangma CH; van der Kwast TH; van Leenders GJ
    Mod Pathol; 2015 Mar; 28(3):457-64. PubMed ID: 25189638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
    Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
    Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
    [No Abstract]   [Full Text] [Related]  

  • 11. Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
    Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Compérat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJ
    Histopathology; 2016 Sep; 69(3):441-9. PubMed ID: 27028587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
    McKenney JK; Wei W; Hawley S; Auman H; Newcomb LF; Boyer HD; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Tretiakova MS; Vakar-Lopez F; Carroll PR; Cooperberg MR; Gleave ME; Lance RS; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; Brooks JD
    Am J Surg Pathol; 2016 Nov; 40(11):1439-1456. PubMed ID: 27635949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
    Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
    Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
    Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
    Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
    Ann Diagn Pathol; 2021 Jun; 52():151733. PubMed ID: 33780691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
    Hesterberg AB; Rios BL; Wolf EM; Tubbs C; Wong HY; Schaffer KR; Lotan TL; Giannico GA; Gordetsky JB; Hurley PJ
    J Pathol Clin Res; 2021 May; 7(3):271-286. PubMed ID: 33600062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
    Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
    Gottipati S; Warncke J; Vollmer R; Humphrey PA
    Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
    Silva-Rodríguez J; Colomer A; Sales MA; Molina R; Naranjo V
    Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.